Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

Similar documents
Oesophagus and Stomach update dysplasia and early cancer

Barrett s Esophagus: Old Dog, New Tricks

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

Earlyoesophagealcancer. dr. Nina Zidar Institute of Pathology Faculty ofmedicine University of Ljubljana Slovenia

American Journal of Gastroenterology. Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma

SAM PROVIDER TOOLKIT

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

Management of Barrett s: From Imaging to Resection

Barrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ

Gland ducts and multilayered epithelium in mucosal biopsies from gastroesophageal-junction region are useful in characterizing esophageal location

Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery

How to stage early BE cancer - EUS or endoscopic removal?

ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

Learning Objectives:

Barrett s Esophagus: Review of Diagnostic Issues and Pre- Neoplastic Lesions

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?

Paris classification (2003) 삼성의료원내과이준행

SAMs Guidelines DEVELOPING SELF-ASSESSMENT MODULES TEST QUESTIONS. Ver. #

Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett s Esophagus

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Endoscopic Submucosal Dissection ESD

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Ablation for Barrett s Esophagus: Burn or Freeze

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Burning Issues in the Esophagus

New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus

Definition of GERD American College of Gastroenterology

Greater Manchester & Cheshire Guidelines for Pathology Reporting of Oesophageal and Gastric Malignancy

Editorial: Advanced endoscopic therapeutics in Barrett s neoplasia; where are we now and where are we heading?

Gregory G. Ginsberg, M.D.

Barrett s Esophagus: Ablate Everyone?

Gastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath

The present staging system for esophageal carcinoma

From reflux to esophageal cancer. Josh Boys, MD TCV 2 nd year indentured servant

Present Day Management of Barrett s Esophagus

COLLECTING CANCER DATA: STOMACH AND ESOPHAGUS

THE USE OF SPECIAL STAINS IN THE DIAGNOSIS OF BARRETT ESOPHAGUS AND BARRETT DYSPLASIA: RECOMMENDATIONS FROM THE RODGER C. HAGGITT GASTROINTESTINAL

Histopathology: gastritis and peptic ulceration

B Barrett neoplasia, early, endoscopic mucosal resection of, in Europe, 297

A218 : Esophagus cancer tissues. (formalin fixed)

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

Adenocarcinoma of the distal esophagus is a recognized

Barrett s Esophagus: What to Do for No Dysplasia, LGD, and HGD?

Henry Moon was one of the giants in academic pathology during my early years.

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines

PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS

College of American Pathologists. Pathology Performance Measures included in CMS 2012 PQRS

Evaluating Treatments of Barrett s Esophagus That Shows High-Grade Dysplasia

Pathology in Slovenian CRC screening programme:

AGA SECTION. Gastroenterology 2016;150:

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

How to treat early gastric cancer? Endoscopy

Gastric and Oesophageal Neuroendocrine tumours. Dr Tim Bracey, Consultant Pathologist MBChB PhD MRCS FRCPath

Professor, Department of Endoscopic Diagnostic and Therapeutics, Chiba University School of Medicine

The esophagogastric junction (EGJ), the region between

A Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis

Endoscopic Radiofrequency Ablation or Cryoablation for Barrett s Esophagus

Upper GIT IV Gastric cancer

Common Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

EMR, ESD and Beyond. Peter Draganov MD. Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Florida

Esophageal cancer: Biology, natural history, staging and therapeutic options

Gastric Extremely Well-Diferentiated Intestinal-Type Adenocarcinoma: A Challenging Lesion to Achieve Complete Endoscopic Resection

Gastric Cancer Histopathology Reporting Proforma

Citation for published version (APA): Phoa, K. Y. N. (2014). Endoscopic management of Barrett s esophagus with dysplasia

The Digestive System Laboratory

Treatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea

Endoscopic UltraSound (EUS) Endoscopic Mucosal Resection (EMR) Moishe Liberman Director C.E.T.O.C.

References. GI Biopsies. What Should Pathologists Assistants Know About Gastrointestinal Histopathology? James M Crawford, MD, PhD

위 ESD 후내시경소견 성균관대학교의과대학내과이준행

CLINICAL EFFECTIVENESS

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Hiatal Hernias and Barrett s esophagus. Dr Sajida Ahad Mercy General Surgery

Update on Colonic Serrated (and Conventional) Adenomatous Polyps

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

Pathology in Slovenian CRC screening programme: Organisation and quality assurance. Snježana Frković Grazio and Matej Bračko

Tumor location is a risk factor for lymph node metastasis in superficial Barrett s adenocarcinoma

Esophageal submucosal mass icd 10

ESMO Preceptorship Gastrointestinal Tumours Valencia October 2017

In 1998, the American College of Gastroenterology issued ALIMENTARY TRACT

Gastroenterology Tutorial

THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 97, No. 1, by Am. Coll. of Gastroenterology ISSN /02/$22.00

Chapter 2 Complications of Gastroesophageal Reflux Disease

ATLAS OF HEAD AND NECK PATHOLOGY METAPLASIA

Characteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu

Medicare Advantage Medical Policy

RFA and Cyrotherapy for Esophageal Disease

Faculty Disclosure. Objectives. State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) 24/11/2014

Volumetric laser endomicroscopy can target neoplasia not detected by conventional endoscopic measures in long segment Barrett s esophagus

Management of Barrett s Esophagus. Case Presentation

Rectal Cancer Cookbook Update. A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux

Citation Acta Medica Nagasakiensia. 1992, 37

ESD for EGC with undifferentiated histology

Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

Transcription:

Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

Br J Surg 38 oct. 1950

Definition of Barrett's esophagus A change in the esophageal epithelium of any length that can be recognized at endoscopy and is confirmed to have columnar epithelium / intestinal metaplasia by biopsy. Practice Parameters Committee of American College of Gastroenterology, Am J Gastroenterol 1998;93:1028-31 British Society of Gastroenterology (BSG), Gut 2006;55:44

Endoscopy Gastroesophageal junction: Western world: Proximal border of gastric folds. Japan: Pallisading longitudinal vessels.

Pathology Squamo-columnar junction: USA: specialized intestinal metaplasia. UK/Japan: all columnar metaplasia. Europe: specialized intestinal metaplasia.

Gross anatomy of a BE resection specimen Squamocolumnar junc/on

Define Barrett's in Biopsy Definition: A change in the esophageal epithelium of any length recognized at endoscopy and confirmed to have columnar epithelium / IM by biopsy. Challenge for pathologist: Define origin of the biopsy. Identify intestinal metaplasia.

Biopsy distal esophagus: Barrett?

Biopsy distal esophagus: Barrett? Gastric type mucosa. Intestinal metaplasia? Differential includes hiatus hernia.

Biopsy distal esophagus: Barrett?

Multilayered Epithelium with Pseudogoblets

Intestinal Metaplasia vs Pseudogoblet cells

Definition of Barrett's: Mucin Histochemistry

Definition of Barrett's: CDX2 Expression

Diagnostic of Barrett's: Esophageal Duct

Diagnostic of Barrett's: Squamous Patches

Distal Esophagus: Barrett's? Dysplasia?

Revised Vienna Classification of Gastrointestinal Epithelial Neoplasia 1. Negative for dysplasia 2. Indefinite for dysplasia 3. Low grade dysplasia 4. Mucosal high-grade neoplasia (HGD) - High grade adenoma / dysplasia - Non invasive carcinoma (CIS) - Intramucosal carcinoma 5. Submucosal invasion by carcinoma Schlemper RJ et al. J Gastroenterol 2001;36:445-456

Based on the Revised Vienna Classification No dysplasia Indefinite for dysplasia Low grade dysplasia High grade dysplasia Intramucosal carcinoma Invasive adenocarcinoma

Biopsy Report Intestinal metaplasia. When dysplasia is present, grade. HGD / EAC does not automatically implicate esophagectomy anymore. Local resection (mucosectomy) as staging modality.

Multiband Mucosectomy (MBM) ligate-and-cut

ER-Cap Technique lift-suck-and-cut

Preperation of ER specimen Endoscopist should loosely pin down specimen on paraffin block or cork to prevent from curling up (creates artefact). Deliver up-side-down (specimen down) in formalin and fixate overnight.

Usually non- marked specimen, photograph, ink,

Slices, each 2 to 3 mm 1 2 3 4 5 6 7 8 9 10

2 to 3 slices per casece 2 to 3 secdons per slice

Conclusion ER Specimen Dysplasia / carcinoma / type Differentiation grade Depth of invasion Submucosal invasion Vaso-invasion Vertical margin (mm) / radicality Lateral margin (not in piecemeal resection) Intestinal metaplasia

Risk Factors Essential in sign out, relative risk factors for esophagectomy: 1. Invasion in submucosa. 2. Poor differentiation grade (solid tumor, signet cell carcinoma). 3. Vaso-invasive growth.

Risk Factor: Submucosal Mucosal vs Submucosal Disease M1 high grade dysplasia. M2 intramucosal carcinoma confined to lamina propria. M3 intramucosal carcinoma invasion in musc. mucosa. SM-1: - 500mm of the submucosa. SM-2: 500mm-1000mm. SM-3: > 1000mm.

Westerterp et al. 2004 Vieth et al. 2004 pt1 (m1) pt1 (m2) pt1 (m3) pt1 (m1) pt1 (m2) pt 1 (m1) pt 1 (m2) pt 1 (m3) Sm-1 pt1 (m3) Sm-1 pt 1 (m4) Sm-1

Risk Factor: Submucosal

Desmin stain

Invasion in Muscularis Mucosae?

p53 IHC tumor tumor Esophageal duct

Extensive Esophageal Gland Involvement

Submucosal Invasion?

Risk Factor: Poor Differentiation

Risk Factor: Vaso-invasive Growth

Vaso-invasive Growth

Vaso-invasive Growth

Vaso-invasive Growth

Extension in Esophageal Duct CD31 IHC

Patient 29 years old

Surgical Resection Specimen

microscopic tumor focus

2 of 16 Lymph Nodes Show Metastasis

Summary ER Prevent non-interpretable slide. Train endoscopist for pinning down. Gross: train resident (staff). Parallel slices at regular interval (2-3 mm). Not too many slices per block. Train lab technician in cutting slides.

Summary ER Analyze for risk factors: radicality poor differentiation submucosal invasion vaso-invasive growth Lateral margin not important in piecemeal resection.

Summary ER Use full stains: desmin and p53. Don t overestimate depth of invasion at the edge of specimen (desmin stain). Don t overestimate non-radical excision needle artefact.

Questions?